OSA screening in COPD
- Conditions
- COPDObstructive Sleep ApnoeaRespiratory - Chronic obstructive pulmonary diseaseRespiratory - Sleep apnoea
- Registration Number
- ACTRN12607000288426
- Lead Sponsor
- Woolcock Institute of Medical Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 360
Group 1 (Control group): symptoms of sleep apnoea (including snoring, choking, witnessed apneas and daytime sleepiness) and/or co morbidities including obesity, hypertension and the metabolic syndrome that are non smokers with < 5 pack year history. Group 2 COPD patients who are smokers or ex smokers with > 10 pack year history of smoking and symptoms of OSA, and/or co morbidities including obesity, hypertension and the metabolic syndrome, are able to give informed consent.
Inability to comply with procedures, previous diagnosis of other respiratory and/or sleep disorders, and current treatment with continuous positive airways pressure, a tracheostomy or home oxygen as well as poorly controlled other medical conditions.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method